Situación actual de la Artritis Idiopática Juvenil

ARTRITIS IDIOPATICA JUVENIL ,[object Object],[object Object],[object Object],[object Object]

( JIA,JCA en europa,JRA en usa)

ARTRITIS IDIOPATICA JUVENIL ,[object Object]

CRITERIOS PARA EL DIAGNOSTICO DE AIJ ,[object Object],[object Object],[object Object],[object Object]

AIJ CLASIFICACION ILAR ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

AIJ: SUBTIPO OLIGOARTICULAR ,[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object]

AIJ: SUBTIPO POLIARTICULAR ,[object Object],[object Object]

[object Object],[object Object],[object Object]

AIJ SISTEMICA ,[object Object],[object Object],[object Object]

AIJ SISTEMICA ,[object Object],[object Object],[object Object],[object Object]

ASOCIACION CON HLA ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

OBJETIVOS DEL TRATAMIENTO ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

AIJ: Tratamiento ,[object Object],[object Object],[object Object],[object Object]

AIJ: Plan de Trabajo ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

VARIABLES DE SEGUIMIENTO EN AIJ ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

DEFINICION DE MEJORIA EN AIJ ,[object Object],[object Object],[object Object]

TRATAMIENTO FARMACOLOGICO ,[object Object],[object Object],[object Object],[object Object]

AINES EN ARJ ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object]

NUEVOS AINES EN AIJ ,[object Object],[object Object],[object Object],[object Object]

AINES ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

DMARDS Drogas antireumaticas modificadoras del curso de la enfermedad

FARMACOS ANTIRREUMATICOS DE ACCION LENTA E INMUNOSUPRESORES ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

MTX ,[object Object],[object Object],[object Object],[object Object],[object Object]

Artritis Idiopatica juvenil: Efectos adversos de DMARDs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Adaptado de Paget. Primer on Rheum Dis . 11th edition. 1997:168.

CORTICOIDES EN AIJ ,[object Object],[object Object],[object Object]

CORTICOIDES EN AIJ ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

DROGAS ANTI TNF ,[object Object],[object Object],[object Object]

[object Object],[object Object],Lovell Dj. Arthritis Rheum 2006; 54: 1987

[object Object],Ruperto N. Arthritis Rheum. 2007; 56: 3096

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],Ruperto N.Ann Rheum Dis 2007; 66 Supl II 185

Terapia biológica ,[object Object],[object Object],[object Object]

[object Object],Imagawa T. Ann Rheum Dis. 2007; 66supl II: 550

Terapia biológica ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],Ruperto N. Ann Rheum Dis. 2006; 65 Supl II: 248

[object Object],[object Object],[object Object],Verbist C. Ann Rheum Dis 2008 (Abstract EULAR 2008)

AIJ TRATAMIENTO ,[object Object]

Arj tratamiento ,[object Object]

AIJ: Factores que influencian el seguimiento ,[object Object],[object Object],[object Object],[object Object]

ARJ SEGÚN DIAGNOSTICO DE INGRESO 1977 – 1991 EN EL INSN. TOTAL : 40

ARJ : SEGÚN GENERO Y GRUPO ETAREO 1977 – 1991 EN EL INSN. TOTAL : 40

ARJ :SEGÚN FORMA DE INICIO POR GENERO 1977 – 1991 EN EL INSN. TOTAL : 40

ARJ: En el INSN, 1992-1996 TOTAL : 210 Casos

AIJ.-PREVALENCIA ISN ,[object Object],[object Object],[object Object],[object Object],[object Object]

AIJ en el INSN ,[object Object],[object Object],[object Object],[object Object],[object Object]

AIJ en el IESN ,[object Object],[object Object],[object Object],[object Object]

AIJ en el IESN ,[object Object],[object Object],[object Object],[object Object],[object Object]

AIJ en el IESN ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Situación actual de la Artritis Idiopática Juvenil

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Viewers also liked

Viewers also liked (20)

Similar to Situación actual de la Artritis Idiopática Juvenil

Similar to Situación actual de la Artritis Idiopática Juvenil (20)

More from Cuerpomedicoinsn

More from Cuerpomedicoinsn (20)

Recently uploaded

Recently uploaded (20)

Situación actual de la Artritis Idiopática Juvenil